Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$5.02 - $9.82 $1,505 - $2,946
-300 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.23 - $24.73 $969 - $7,419
300 New
300 $3,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0

About NeuroMetrix, Inc.


  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $30.3M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.